No. |
Chromosome Location |
Chromatin state |
Cell line |
Tissue |
1 |
chr3:56717800-56726800 |
Weak transcription |
Primary hematopoietic stem cells G-CSF-mobilized Male |
--
|
2 |
chr3:56718000-56727000 |
Weak transcription |
Primary hematopoietic stem cells |
blood
|
3 |
chr3:56718000-56727400 |
Weak transcription |
HSMMtube |
muscle
|
4 |
chr3:56718400-56727000 |
Weak transcription |
HSMM |
muscle
|
5 |
chr3:56718800-56726600 |
Weak transcription |
Primary hematopoietic stem cells short term culture |
blood
|
6 |
chr3:56719000-56725800 |
Weak transcription |
Fetal Thymus |
thymus
|
7 |
chr3:56722400-56726600 |
Weak transcription |
Primary B cells from peripheral blood |
blood
|
8 |
chr3:56722400-56727000 |
Weak transcription |
Primary B cells from cord blood |
blood
|
9 |
chr3:56722600-56726800 |
Weak transcription |
Primary T helper naive cells fromperipheralblood |
blood
|
10 |
chr3:56723600-56727000 |
Weak transcription |
GM12878-XiMat |
blood
|
11 |
chr3:56725000-56726000 |
Enhancers |
Placenta |
Placenta
|
12 |
chr3:56725200-56725400 |
Enhancers |
Adipose Derived Mesenchymal Stem Cell Cultured Cells |
ES cell derived
|
13 |
chr3:56725200-56725600 |
Enhancers |
Breast variant Human Mammary Epithelial Cells (vHMEC) |
Breast
|
14 |
chr3:56725200-56725800 |
Enhancers |
Mesenchymal Stem Cell Derived Adipocyte Cultured Cells |
ES cell derived
|
15 |
chr3:56725200-56725800 |
Enhancers |
Foreskin Keratinocyte Primary Cells skin02 |
Skin
|
16 |
chr3:56725200-56725800 |
Flanking Active TSS |
A549 |
lung
|
17 |
chr3:56725200-56726000 |
Enhancers |
Placenta Amnion |
Placenta Amnion
|
18 |
chr3:56725200-56726000 |
Enhancers |
Hela-S3 |
cervix
|
19 |
chr3:56725200-56726000 |
Enhancers |
NHEK |
skin
|
20 |
chr3:56725200-56726200 |
Enhancers |
Foreskin Keratinocyte Primary Cells skin03 |
Skin
|
21 |
chr3:56725200-56726200 |
Enhancers |
HMEC |
breast
|
22 |
chr3:56725200-56726800 |
Enhancers |
Dnd41 |
blood
|